Bill Gates: West Must Finance Global Vaccine Distribution Network If It Wants To Defeat COVID-19
Oxford to study anti-inflammatory drug Humira as potential Covid-19 treatment
Logos LP – Everything is F*cked
These 2 Penny Stocks Are Poised for a Massive Rally, Says Roth Capital
A Primer For The Media On Viruses, Vaccines, & COVID-19
Breakthrough Research On Severe COVID-19 Infections Opens Door To New Treatment
UofA lab uncovers new mechanism of action against SARS-CoV-2 by antiviral drug remdesivir
Aerpio starts trial of drug for COVID blood vessel damage
EU regulator backs dexamethasone as Covid-19 treatment
Roche says a second trial of Actemra revives hopes for IL-6. What now?
Lilly’s antibody therapy cuts hospitalisation rates in COVID-19
Gilead Sciences: Don’t Underestimate This Pharma Giant’s Growth Potential, Says Analyst
Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy
Eyeing emergency use of COVID-19 drug, Humanigen partners with Lonza to make it
Eli Lilly’s rheumatoid arthritis drug accelerates recovery in Covid-19 patients
Gilead Sciences Close To Inking $20B Immunomedics Deal- Report
Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Exclusive: U.S. hospitals turn down remdesivir, limit use to sickest Covid-19 patients
A primer on viruses, vaccines, and therapies
Wednesday’s Market Snapshot: Here’s What You Need To Know Right Now
Dr. Reddy’s Rolls Out Remdesivir For Covid-19 Treatment In India
EU regulators begin fast review of dexamethasone for COVID-19
Steroids cut death rates among critically ill Covid-19 patients, major study finds
A ‘Human’ Touch vs. COVID-19
Gilead’s Remdesivir Now Authorized For All Hospitalized Covid-19 Patients
AbbVie and Harvard team up to find new drugs for the next new viruses
Antiviral used to treat cat coronavirus also works against SARS-CoV-2
UPDATED: Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight
UH selected as clinical trial site to test Pfizer and BioNTech’s COVID-19 vaccine
Sonnet Bio Spikes 70% In Pre-Market On FDA Covid-19 Plasma Nod